通过DAF-16和热冲击因子调节衰老和与年龄相关的疾病
Ao-Lin Hsu1, Coleen T Murphy, Cynthia Kenyon
1Department of Biochemistry and Biophysics, University of California, San Francisco, CA 94143-2200, USA.
Science (New York, N.Y.)
|May 17, 2003
概括
在C. elegans中,热冲击因子HSF-1会影响衰老. 它的过度表达延长了寿命,它与DAF-16合作激活长寿基因,可能延迟与年龄相关的疾病.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 衰老的研究研究.
背景情况:
- 热冲击反应是由转录因子HSF-1调节的.
- 在Caenorhabditis elegans中,HSF-1在衰老过程中发挥作用.
- DAF-16是另一种已知影响寿命的转录因子.
研究的目的:
- 研究HSF-1在衰老和寿命调节中的作用.
- 确定HSF-1,DAF-16和长寿途径之间的关系.
- 探索HSF-1,小热冲击蛋白和与年龄相关的疾病之间的联系.
主要方法:
- 在C. elegans.中对HSF-1活动 (减少和过度表达) 的基因操纵.
- 针对HSF-1水平变化的寿命分析.
- 调查延长寿命的daf-2突变的遗传要求,重点关注HSF-1和DAF-16.
主要成果:
- 降低HSF-1活性加速衰老并缩短寿命.
- 过度表达的HSF-1延长了C. elegans的寿命.
- 与DAF-16一起,HSF-1对于达夫-2突变至关重要,可以延长寿命.
- HSF-1和DAF-16共同激活基因,包括小热冲击蛋白,促进长寿.
结论:
- 在C. elegans中,HSF-1是衰老和寿命的关键调节者.
- HSF-1和DAF-16的协同作用对于长寿至关重要.
- 由HSF-1和DAF-16激活的小型热冲击蛋白质是延长寿命的重要媒介,并可能防止蛋白质聚合疾病.
相关概念视频
01:19The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:26Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...